PMC:7696151 / 64724-64977 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1883","span":{"begin":3,"end":8},"obj":"Species"},{"id":"1897","span":{"begin":32,"end":35},"obj":"Chemical"},{"id":"1916","span":{"begin":19,"end":26},"obj":"Disease"}],"attributes":[{"id":"A1883","pred":"tao:has_database_id","subj":"1883","obj":"Tax:10090"},{"id":"A1897","pred":"tao:has_database_id","subj":"1897","obj":"MESH:D006886"},{"id":"A1916","pred":"tao:has_database_id","subj":"1916","obj":"MESH:D003092"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In mouse models of colitis, the HCQ methacryloylated form (30 mg/kg) avoided systemic absorption, accumulating in the gastrointestinal tract, where alterations in the immune homeostasis of the intestinal mucosa had a positive impact on the disease [74]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T116","span":{"begin":19,"end":26},"obj":"Phenotype"}],"attributes":[{"id":"A116","pred":"hp_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/HP_0002583"}],"text":"In mouse models of colitis, the HCQ methacryloylated form (30 mg/kg) avoided systemic absorption, accumulating in the gastrointestinal tract, where alterations in the immune homeostasis of the intestinal mucosa had a positive impact on the disease [74]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T415","span":{"begin":0,"end":253},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In mouse models of colitis, the HCQ methacryloylated form (30 mg/kg) avoided systemic absorption, accumulating in the gastrointestinal tract, where alterations in the immune homeostasis of the intestinal mucosa had a positive impact on the disease [74]."}